Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs Post date 9 September 2021 ← Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline → Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain